United States

Gene Techno Science Co Ltd (4584.T)

4584.T on Tokyo Stock Exchange

18 Aug 2017
Change (% chg)

¥-20 (-1.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4584.T


Gene Techno Science Co., Ltd. is primarily engaged in the development of biopharmaceuticals including biosimilars and new drugs. The Biosimilars segment develops biosimilars of equal or superior quality to existing biopharmaceuticals with patents expired, and conducts the nonclinical studies. It builds in-house or introduces... (more)


Beta: 3.17
Market Cap(Mil.): ¥11,577.19
Shares Outstanding(Mil.): 9.57
Dividend: --
Yield (%): --


  4584.T Industry Sector
P/E (TTM): -- 78.89 32.56
EPS (TTM): -105.57 -- --
ROI: -27.93 2.83 14.89
ROE: -28.04 5.09 16.13

BRIEF-Gene Techno Science sets up JV

* Says it established Sapporo-based JV with AIN HOLDINGS INC , North Pacific Bank,LTD. and a Sapporo-based investment limited liability partnership

Jun 06 2017

BRIEF-Gene Techno Science announces change of chairman and president

* Says it appoints current president Masanari Kawaminami as new chairman, Masaharu Tani as new president, effective on April 1

Mar 14 2017

BRIEF-Gene Techno Science forms cooperation with ITOCHU CHEMICAL FRONTIER Corp

* Says the co to jointly develop biosimilars technology with ITOCHU CHEMICAL FRONTIER Corporation

Mar 09 2017

BRIEF-Gene Techno Science signs joint research and development contract with Juntendo University

* Says it signed a joint research and development contract for new immunosuppressive therapy with Juntendo University on Feb. 27

Feb 27 2017

Earnings vs. Estimates